Table 2 Baseline Characteristics of MMD patients according to the quartiles of CT (liver/spleen)

Age, y, mean ± SD

38.14 ± 14.36

39.36 ± 14.36

32.32 ± 17.02

34.17 ± 17.03

0.043

-0.118

0.059

Sex(male), n (%)

37(57.8)

36(56.3)

26(40)

17(26.6)

0.001*

-0.247

< 0.001*

Clinical features, mean ± SD

 Heart rate, bpm

79.42 ± 6.125

78.16 ± 7.44

79.48 ± 7.53

78.47 ± 5.75

0.611

-0.051

0.416

 SBP, mmHg

134.02 ± 17.23

133.84 ± 14.14

127.63 ± 13.57

125.61 ± 15.47

0.002*

-0.186

0.003*

 DBP, mmHg

82.41 ± 11.39

82.39 ± 9.536

80.58 ± 9.04

79.00 ± 11.41

0.232

-0.067

0.281

 BMI, kg/m2

26.91 ± 5.10

25.34 ± 4.81

23.12 ± 4.42

22.80 ± 3.93

< 0.001*

-0.314

< 0.001*

History of risk factor, n (%)

Hypertension

24(37.5)

28(43.8)

16(24.6)

15(23.4)

0.034

-0.147

0.019*

Diabetes

12(18.8)

15(23.4)

6(9.2)

3(4.7)

0.008*

-0.182

0.003*

Hypercholesterolemia

11(17.2)

9(14.1)

3(4.6)

7(10.9)

0.144

-0.098

0.116

Smoking

10(15.6)

15(23.4)

5(7.7)

8(12.5)

0.082

-0.079

0.204

Laboratory results, median (IQR)

 HDL-C, mmol/L

1.14(0.34)

1.25(0.45)

1.34(0.35)

1.35(0.44)

0.007*

0.211

0.001*

 LDL-C, mmol/L

2.385(1.52)

2.245 (1.31)

2.07(0.88)

2.205(1.11)

0.543

-0.025

0.691

 TG, mmol/L

1.51(1.33)

1.08(0.93)

0.89 (0.73)

1.07(0.58)

< 0.001*

-0.237

< 0.001*

 TC, mmol/L

4.34(1.52)

3.97(1.46)

3.76(0.96)

3.99(1.39)

0.614

-0.031

0.618

 GGT, mmol/L

27.15(21.2)

24.1(22.1)

16.8(14.8)

15.5(8.4)

< 0.001*

-0.365

< 0.001*

 ALT, U/L

25(26.2)

20.5(0.34)

14.5(11.8)

14.55(11.9)

0.001*

-0.339

< 0.001*

 AST, U/L

19.75(12.4)

16.7(4.6)

17(7.3)

18(8.2)

0.033*

0.146

0.019*

 APO-A1, g/L

1.21(0.33)

1.30(0.36)

1.30(0.29)

1.30 (0.38)

0.381

0.117

0.062

 APO-B, g/L

0.815(0.368)

0.86(0.328)

0.74(0.235)

0.785(0.24)

0.130

-0.106

0.090

 HCY, µmol/L

12.94(6.87)

12.985(6.28)

11.23(4.75)

12.115(6.37)

0.715

-0.072

0.250

 Cr, µmol/L

54.55(24.7)

54.15(25.1)

51.60(19.8)

50.60(19.4)

0.231

-0.124

0.047*

 UA, µmol/L

350.1(121.6)

316.45(118)

280.1(93.1)

294.95(95.2)

< 0.001*

-0.296

< 0.001*

 WBC count, 10⁹/L

7.385(3.57)

7.1(1.96)

6.93(2.28)

6.75(2.84)

0.519

-0.056

0.373

 LY count, 10⁹/L

2.02(1.06)

2.01(0.82)

1.89(1.11)

1.81(0.97)

0.830

-0.075

0.228

 PLT count, 10⁹/L

256.5(59)

266(95)

256(82)

254.5(96)

0.279

-0.035

0.579

Primary symptom n (%)

0.079

-0.091

0.145

 Infarction

24(37.5)

31(48.4)

27(41.5)

17(24.7)

 Non-infarction

40(62.5)

33(51.6)

38(58.5)

47(73.4)

Suzuki stage, n (%)

0.326

0.086

0.170

 1–3

51(79.7)

49(76.6)

43(66.2)

46(71.9)

 4–6

13(20.3)

15(23.4)

22(33.8)

18(28.1)